nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupranolol—Bopindolol—HTR1B—attention deficit hyperactivity disorder	0.0105	0.379	CrCbGaD
Bupranolol—Penbutolol—HTR1B—attention deficit hyperactivity disorder	0.01	0.361	CrCbGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00971	0.00999	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00955	0.00982	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00943	0.0097	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00878	0.00904	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00762	0.00784	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00745	0.00766	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00735	0.00756	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00733	0.00754	CbGpPWpGaD
Bupranolol—ADRB3—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00732	0.00753	CbGpPWpGaD
Bupranolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.00724	0.26	CrCbGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00717	0.00737	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00708	0.00728	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00693	0.00713	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00686	0.00705	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00674	0.00693	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00671	0.0069	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00666	0.00685	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00659	0.00678	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00651	0.0067	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0064	0.00659	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00626	0.00644	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0062	0.00638	CbGpPWpGaD
Bupranolol—ADRB3—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00615	0.00633	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00607	0.00624	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00595	0.00612	CbGpPWpGaD
Bupranolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00591	0.00608	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00582	0.00599	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00577	0.00593	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00567	0.00583	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00564	0.0058	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0056	0.00576	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00554	0.0057	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00547	0.00563	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00521	0.00536	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0051	0.00525	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00436	0.00448	CbGpPWpGaD
Bupranolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00434	0.00447	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00427	0.00439	CbGpPWpGaD
Bupranolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00425	0.00437	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00417	0.00429	CbGpPWpGaD
Bupranolol—ADRB3—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00414	0.00426	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00409	0.0042	CbGpPWpGaD
Bupranolol—ADRB3—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00409	0.0042	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00406	0.00417	CbGpPWpGaD
Bupranolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00365	0.00376	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00358	0.00368	CbGpPWpGaD
Bupranolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00357	0.00367	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0035	0.0036	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00298	0.00307	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00289	0.00298	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00283	0.00291	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00272	0.0028	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00267	0.00274	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00248	0.00255	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00248	0.00255	CbGpPWpGaD
Bupranolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00246	0.00253	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00243	0.0025	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00243	0.0025	CbGpPWpGaD
Bupranolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00243	0.0025	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00242	0.00249	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00241	0.00248	CbGpPWpGaD
Bupranolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0024	0.00247	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00237	0.00244	CbGpPWpGaD
Bupranolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00237	0.00244	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00236	0.00242	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0023	0.00237	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00229	0.00236	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00223	0.00229	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00219	0.00225	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00216	0.00223	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00212	0.00218	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00212	0.00218	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00208	0.00214	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00208	0.00214	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00208	0.00214	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00203	0.00209	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00202	0.00207	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00197	0.00203	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00191	0.00197	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00189	0.00194	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00188	0.00193	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00185	0.00191	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00185	0.0019	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00173	0.00178	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00168	0.00173	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00165	0.00169	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00162	0.00166	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00162	0.00166	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00158	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00158	0.00163	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00155	0.00159	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00158	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00151	0.00155	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.0015	0.00155	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00147	0.00151	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00145	0.0015	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00144	0.00148	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00144	0.00148	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00143	0.00147	CbGpPWpGaD
Bupranolol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00141	0.00145	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00141	0.00145	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00141	0.00145	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.0014	0.00144	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00137	0.00141	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00137	0.00141	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00136	0.0014	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00134	0.00138	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00133	0.00137	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00132	0.00136	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00132	0.00135	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0013	0.00134	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00129	0.00133	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00128	0.00132	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00127	0.00131	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00126	0.0013	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00126	0.00129	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00124	0.00127	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00123	0.00127	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00123	0.00127	CbGpPWpGaD
Bupranolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00124	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00121	0.00124	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0012	0.00123	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00117	0.0012	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00117	0.0012	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00115	0.00118	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00113	0.00117	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00111	0.00115	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00111	0.00114	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0011	0.00113	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0011	0.00113	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00112	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00108	0.00111	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00107	0.0011	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00104	0.00107	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00103	0.00105	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.001	0.00103	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000961	0.000988	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000959	0.000987	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000949	0.000976	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000938	0.000965	CbGpPWpGaD
Bupranolol—ADRB3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000922	0.000948	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000913	0.000939	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000913	0.000939	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000895	0.00092	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000893	0.000919	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000892	0.000917	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000875	0.0009	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000872	0.000897	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000864	0.000888	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000849	0.000873	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000849	0.000873	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000845	0.000869	CbGpPWpGaD
Bupranolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000838	0.000862	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000838	0.000862	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00083	0.000854	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000829	0.000853	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000829	0.000853	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000825	0.000849	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000822	0.000846	CbGpPWpGaD
Bupranolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00082	0.000844	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00082	0.000844	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000812	0.000836	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000811	0.000834	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000809	0.000832	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000808	0.000831	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000798	0.000821	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000795	0.000817	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000793	0.000816	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000781	0.000803	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000771	0.000793	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000764	0.000786	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000747	0.000768	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000744	0.000765	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000734	0.000755	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00073	0.000751	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000725	0.000746	CbGpPWpGaD
Bupranolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000718	0.000739	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000714	0.000735	CbGpPWpGaD
Bupranolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000703	0.000723	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000675	0.000695	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00062	0.000638	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000607	0.000624	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00057	0.000586	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000563	0.000579	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00056	0.000576	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000558	0.000574	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000551	0.000567	CbGpPWpGaD
Bupranolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000547	0.000563	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000542	0.000558	CbGpPWpGaD
Bupranolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000535	0.00055	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00053	0.000545	CbGpPWpGaD
Bupranolol—ADRB3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000521	0.000536	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000504	0.000518	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000493	0.000507	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000492	0.000506	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00049	0.000504	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00049	0.000504	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000488	0.000502	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000481	0.000495	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00048	0.000494	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00048	0.000493	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000479	0.000493	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000477	0.000491	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000474	0.000487	CbGpPWpGaD
Bupranolol—ADRB3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000473	0.000486	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000471	0.000484	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000469	0.000483	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000469	0.000483	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000463	0.000477	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00046	0.000474	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000458	0.000471	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000455	0.000468	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000448	0.00046	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000443	0.000456	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000441	0.000454	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000441	0.000454	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000436	0.000448	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000434	0.000446	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000434	0.000446	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000432	0.000444	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00043	0.000443	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000428	0.00044	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000426	0.000438	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000421	0.000433	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000401	0.000412	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000399	0.00041	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000392	0.000403	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000333	0.000342	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000325	0.000335	CbGpPWpGaD
Bupranolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000309	0.000318	CbGpPWpGaD
Bupranolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000302	0.000311	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000291	0.000299	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000284	0.000293	CbGpPWpGaD
Bupranolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000281	0.000289	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000279	0.000287	CbGpPWpGaD
Bupranolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000275	0.000282	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00027	0.000278	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000264	0.000272	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000262	0.000269	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000257	0.000265	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000256	0.000263	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000254	0.000261	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000252	0.000259	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000249	0.000256	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000237	0.000244	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000232	0.000238	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000166	0.000171	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000162	0.000167	CbGpPWpGaD
Bupranolol—ADRB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000148	0.000152	CbGpPWpGaD
Bupranolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.78e-05	9.04e-05	CbGpPWpGaD
Bupranolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.59e-05	8.84e-05	CbGpPWpGaD
